Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 2 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 3 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 4 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 5 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
FGFR1 5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 6 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 7 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 8 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
FGFR2 2件: FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 9 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
FGFR2 5件: FGFR2, FGFR3, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 10 | Endocytosis 💬 15 genes, 28 drugs (DrugBank) and 51 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 11 | Endocytosis 💬 15 genes, 28 drugs (DrugBank) and 51 diseases |
FGFR2 2件: FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 12 | Endocytosis 💬 15 genes, 28 drugs (DrugBank) and 51 diseases |
FGFR2 3件: FGFR2, FGFR3, PDGFRA 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 13 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases |
FGFR2 1件: FGFR2 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 14 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases |
FGFR2 1件: FGFR2 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 15 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 16 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 17 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 18 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 19 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 20 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR1 6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 21 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 22 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 23 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 24 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 25 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases |
FGFR1 2件: FGFR1, FGFR2 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 26 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases |
FGFR1 4件: FGFR1, FGFR2, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 27 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 28 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 29 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 30 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 31 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 32 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 33 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 34 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 35 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
FGFR1 5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 36 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|
| 37 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 1件: 276 💬
|
| 38 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
FGFR1 3件: FGFR1, FGFR2, FGFR3 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 5件: 51, 85, 89, 227, 228 💬
|
| 39 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases |
FGFR2 1件: FGFR2 💬
|
Palifermin Palifermin 💬
| Palifermin | 013 5件: 13, 36, 38, 39, 65 💬
|